The funding will, in part, support efforts to expand the project's catalog of functional elements and understand their roles in different contexts.
The lead investigators said that Foundation Medicine's NGS test will enable the beginning of targeted treatment within seven days of diagnosis.
In Cell this week: double-strand breaks in the mouse genome, metabolomic features of yeast deletion strains, and more.
The update includes several key initiatives such as a liquid biopsy database, a DoD-led longitudinal study, and NCI cloud collaborations with Amazon and Microsoft.
Scientists at Memorial Sloan Kettering Cancer Center, led by Gabriela Chiosis, revealed how the complexes are important for tumor survival in certain cases.
The large-scale study is designed to advance personalized medicine for pancreatic cancer to help meet the organization's goal of doubling patient survival rates by 2020.
The partners said they will use genetic sequencing and a combination therapy to determine predictors of sustained minimal residual disease negativity.
Though the results are preliminary, they suggest that a simpler method that doesn't require isolation of CTCs could potentially be as effective as current CTC-based approaches for AR-V7 testing.
Researchers saw abbreviated overall survival times in estrogen receptor-positive metastatic breast cancer patients with ESR1 mutations in their cell-free DNA.
The New York Times looks at immunotherapy and its use in cancer treatment.
Holden Thorp is to be the new editor-in-chief of Science and its related journals.
A genetic analysis of salmon scales collected over the course of a century points to a sharp decline in the number of fish returning each year to river in British Columbia, CBC reports.
Adelaide University has suspended the head of an ancient DNA lab as its investigation of workplace bullying continues, Australia's ABC News reports.
In PNAS this week: gene expression profiles of adipocyte subtypes, computational approach for improving plant expressome analysis, and more.